Short- and medium-chain fatty acids enhance the cell surface expression and transport capacity of the bile salt export pump (BSEP/ABCB11)

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 9, 2010, Pages 1005-1012

  Kato, Takuya ^a   Hayashi, Hisamitsu ^a   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bile acid; Bile salt export pump (BSEP); Cholestasis; Fatty acid

Indexed keywords

4 PHENYLBUTYRIC ACID; ACETIC ACID; BILE ACID; BILE SALT EXPORT PUMP; BUTYRIC ACID; CARRIER PROTEIN; FORMIC ACID; HEXANOIC ACID; MEDIUM CHAIN FATTY ACID; OCTANOIC ACID; SHORT CHAIN FATTY ACID; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCB11 PROTEIN, HUMAN; BUTYRIC ACID DERIVATIVE; MESSENGER RNA; OCTANOIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; FATTY ACID TRANSPORT; HALF LIFE TIME; ISOTOPE LABELING; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPORT KINETICS; ANIMAL; CELL CULTURE; CELL MEMBRANE; GENETICS; HUMAN; KIDNEY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPORT AT THE CELLULAR LEVEL; WESTERN BLOTTING;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; BUTYRATES; CELL MEMBRANE; CELLS, CULTURED; DOGS; HUMANS; KIDNEY; OCTANOIC ACIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; CAPRYLATES;

EID: 77954661433     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.04.002     Document Type: Article

References (31)

1. Byrne J.A., Strautnieks S.S., Mieli-Vergani G., Higgins C.F., Linton K.J., Thompson R.J. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology 2002, 123:1649-1658.
2. Gerloff T., Stieger B., Hagenbuch B., Madon J., Landmann L., Roth J., Hofmann A.F., Meier P.J. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J. Biol. Chem. 1998, 273:10046-10050.
3. Hayashi H., Takada T., Suzuki H., Onuki R., Hofmann A.F., Sugiyama Y. Transport by vesicles of glycine- and taurine-conjugated bile salts and taurolithocholate 3-sulfate: a comparison of human BSEP with rat Bsep. Biochim. Biophys. Acta 2005, 1738:54-62.
4. Meier P.J., Stieger B. Bile salt transporters. Annu. Rev. Physiol. 2002, 64:635-661.
5. Noe J., Stieger B., Meier P.J. Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 2002, 123:1659-1666.
6. Trauner M., Boyer J.L. Bile salt transporters: molecular characterization, function, and regulation. Physiol. Rev. 2003, 83:633-671.
7. Jansen P.L., Strautnieks S.S., Jacquemin E., Hadchouel M., Sokal E.M., Hooiveld G.J., Koning J.H., De Jager-Krikken A., Kuipers F., Stellaard F., Bijleveld C.M., Gouw A., Van Goor H., Thompson R.J., Muller M. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999, 117:1370-1379.
8. Strautnieks S.S., Bull L.N., Knisely A.S., Kocoshis S.A., Dahl N., Arnell H., Sokal E., Dahan K., Childs S., Ling V., Tanner M.S., Kagalwalla A.F., Nemeth A., Pawlowska J., Baker A., Mieli-Vergani G., Freimer N.B., Gardiner R.M., Thompson R.J. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 1998, 20:233-238.
9. van Mil S.W., van der Woerd W.L., van der Brugge G., Sturm E., Jansen P.L., Bull L.N., van den Berg I.E., Berger R., Houwen R.H., Klomp L.W. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004, 127:379-384.
10. Crocenzi F.A., Mottino A.D., Cao J., Veggi L.M., Pozzi E.J., Vore M., Coleman R., Roma M.G. Estradiol-17beta-d-glucuronide induces endocytic internalization of Bsep in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G449-G459.
11. Elferink M.G., Olinga P., Draaisma A.L., Merema M.T., Faber K.N., Slooff M.J., Meijer D.K., Groothuis G.M. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G1008-G1016.
12. Lee J.M., Trauner M., Soroka C.J., Stieger B., Meier P.J., Boyer J.L. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000, 118:163-172.
13. Vos T.A., Hooiveld G.J., Koning H., Childs S., Meijer D.K., Moshage H., Jansen P.L., Muller M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998, 28:1637-1644.
14. Hayashi H., Takada T., Suzuki H., Akita H., Sugiyama Y. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11. Hepatology 2005, 41:916-924.
15. Plass J.R., Mol O., Heegsma J., Geuken M., de Bruin J., Elling G., Muller M., Faber K.N., Jansen P.L. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump. J. Hepatol. 2004, 40:24-30.
16. Strautnieks S.S., Byrne J.A., Pawlikowska L., Cebecauerova D., Rayner A., Dutton L., Meier Y., Antoniou A., Stieger B., Arnell H., Ozcay F., Al-Hussaini H.F., Bassas A.F., Verkade H.J., Fischler B., Nemeth A., Kotalova R., Shneider B.L., Cielecka-Kuszyk J., McClean P., Whitington P.F., Sokal E., Jirsa M., Wali S.H., Jankowska I., Pawlowska J., Mieli-Vergani G., Knisely A.S., Bull L.N., Thompson R.J. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 2008, 134:1203-1214.
17. Wang L., Soroka C.J., Boyer J.L. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II. J. Clin. Invest. 2002, 110:965-972.
18. Hayashi H., Sugiyama Y. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps. Hepatology 2007, 45:1506-1516.
19. Miller S.J. Cellular and physiological effects of short-chain fatty acids. Mini Rev. Med. Chem. 2004, 4:839-845.
20. Stoddart L.A., Smith N.J., Milligan G. International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol. Rev. 2008, 60:405-417.
21. Hirasawa A., Hara T., Katsuma S., Adachi T., Tsujimoto G. Free fatty acid receptors and drug discovery. Biol. Pharm. Bull. 2008, 31:1847-1851.
22. Hayashi H., Sugiyama Y. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump BSEP/ABCB11. Mol. Pharmacol. 2009, 75:143-150.
23. Kondo C., Suzuki H., Itoda M., Ozawa S., Sawada J., Kobayashi D., Ieiri I., Mine K., Ohtsubo K., Sugiyama Y. Functional analysis of SNPs variants of BCRP/ABCG2. Pharm. Res. 2004, 21:1895-1903.
24. Mita S., Suzuki H., Akita H., Hayashi H., Onuki R., Hofmann A.F., Sugiyama Y. Vectorial transport of unconjugated and conjugated bile salts by monolayers of LLC-PK1 cells doubly transfected with human NTCP and BSEP or with rat Ntcp and Bsep. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G550-G556.
25. Cui Y., Konig J., Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol. Pharmacol. 2001, 60:934-943.
26. Hinnebusch B.F., Meng S., Wu J.T., Archer S.Y., Hodin R.A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr. 2002, 132:1012-1017.
27. van den Berghe P.V., Stapelbroek J.M., Krieger E., de Bie P., van de Graaf S.F., de Groot R.E., van Beurden E., Spijker E., Houwen R.H., Berger R., Klomp L.W. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin. Hepatology 2009, 50:1783-1795.
28. L.M. van der Velden, J.M. Stapelbroek, E. Krieger, P.V. van den Berghe, R. Berger, P.M. Verhulst, J.C. Holthuis, R.H. Houwen, L.W. Klomp, S.F. van de Graaf, Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate, Hepatology 51 286-296.
29. Abriel H., Loffing J., Rebhun J.F., Pratt J.H., Schild L., Horisberger J.D., Rotin D., Staub O. Defective regulation of the epithelial Na+ channel by Nedd4 in Liddle's syndrome. J. Clin. Invest. 1999, 103:667-673.
30. Staub O., Gautschi I., Ishikawa T., Breitschopf K., Ciechanover A., Schild L., Rotin D. Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J. 1997, 16:6325-6336.
31. Sharma M., Pampinella F., Nemes C., Benharouga M., So J., Du K., Bache K.G., Papsin B., Zerangue N., Stenmark H., Lukacs G.L. Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J. Cell Biol. 2004, 164:923-933.